Rhonda Patrick· PhD
It's even been shown to slow biomarkers of prostate cancer progression and reduce metastasis and tumor growth in preclinical models.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
It's even been shown to slow biomarkers of prostate cancer progression and reduce metastasis and tumor growth in preclinical models.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Prostate cancer is another one that seems to also sort of go hand in hand. I mean, the prostate and prostate inflammation seems to be lowered and one study is showing that men with prostate cancer that were given pretty relatively high doses of sulforaphane, it slowed their doubling rate of the PSA by 86%.
if a person wanted to get 60 milligrams of sulforaphane per day, which was shown to reduce the doubling rate of a marker for prostate cancer by 86%
Men with prostate cancer that were given 60 milligrams of sulfurophane per day, an amount in about 140 gram of fresh broccoli sprouts resulted in the slowing of the doubling rate of a cancer biioarker known as prostate specific antigen or PSA by 86% compared to placebo.
In another study, 35 millig of sulfurophane was used instead of 60 millig. And while it theoretically still slowed the growth of prostate cancer, it only increased the average PSA doubling time by 57% which while impressive isn't quite as jaw-dropping as the 86% from the previous study.
the prostate seems to be one that at least clinically there's been a few studies showing that sulforaphane ranging in dose and the higher the dose the more robust the effect so 60 milligrams of sulforaphane a day was shown to slow the the biomarker prostate specific antigen or psa which people with um you know early prostate cancer you know or risk of it or whatever have um and so slowing that by 86 is certainly you know a good thing
So men with low-grade prostate cancer that were supplementing with about 60 milligrams of sulforaphane a day slowed the doubling of their PSA antigen which is with the major biioarker that's used to sort of monitor prostate cancer progression. Um, it was slowed by about 86%.